Report cover image

Spatial OMICS Market Growth, Size, Trends Analysis - By Technology, By Product, By Application, By Workflow, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Oct 08, 2025
Length 257 Pages
SKU # SPER20519994

Description

Spatial OMICS Market Introduction and Overview

According to SPER Market Research, ‘Global Spatial OMICS Market Size- By Technology, By Product, By Application, By Workflow, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Spatial OMICS Market is predicted to reach 3253.89 million by 2034 with a CAGR of 16.52%.

Spatial OMICS pertains to the investigation of integrating various analyses including proteomics, lipidomics, genomics, epigenomics, transcriptomics, and metabolomics. Additionally, Spatial OMICS melds molecular analysis with specific information regarding cell localization within the tissue. This field enables researchers to pinpoint gene activity within tissue samples as well as to delineate the regions where such activity is occurring. Furthermore, it aids in comprehending the biological processes underpinning diseases.

Restraints: The spatial OMICS market experiences notable constraints stemming from the challenges associated with managing extensive and complex datasets produced by this technology. Spatial OMICS produces a substantial volume of multi-dimensional data, which encompasses spatial coordinates, gene expression levels, and cellular interactions. The analysis and management of these data demand considerable computational resources, specialized software, and proficient data scientists.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Technology, By Product, By Application, By Workflow, By End-User

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

10x Genomics, Akoya Biosciences, Inc, Bio-Techne Corporation, BioSpyder, Inc, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics (Hologic, Inc), Ionpath, Inc, Millennium Science Pty Ltd, NanoString Technologies, Inc.

Global Spatial OMICS Market Segmentation:

By Technology: Based on the Technology, Global Spatial OMICS Market is segmented as; Spatial transcriptomics, Spatial genomics, Spatial proteomics.

By Product: Based on the Product, Global Spatial OMICS Market is segmented as; Instruments, Consumable, Software.

By Application: Based on the Application, Global Spatial OMICS Market is segmented as; Diagnostics, Translation research, Drug discovery and development, Single cell analysis, Cell biology, other application.

By Workflow: Based on the Workflow, Global Spatial OMICS Market is segmented as; Sample preparation, Instrumental analysis, Data analysis.

By End-User: Based on End-User, Global Spatial OMICS Market is segmented as; Academic & research institutes, Pharmaceutical and biotechnology companies, Contract research organizations, Other end-users.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

257 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Spatial OMICS Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Spatial OMICS Market
7. Global Spatial OMICS Market, By Technology (USD Million) 2021-2034
7.1. Spatial transcriptomics
7.2. Spatial genomics
7.3. Spatial proteomics
8. Global Spatial OMICS Market, By Product (USD Million) 2021-2034
8.1. Instruments
8.1.1. Sequencing platforms
8.1.2. IHC
8.1.3. Microscopy
8.1.4. Flow cytometry
8.1.5. Mass spectrometry
8.1.6. Other types
8.2. Consumables
8.3. Software
8.3.1. Bioinformatics tools
8.3.2. Imaging tools
8.3.3. Storage & management databases
9. Global Spatial OMICS Market, By Application (USD Million) 2021-2034
9.1. Diagnostics
9.2. Translation research
9.3. Drug discovery and development
9.4. Single cell analysis
9.5. Cell biology
9.6. Other applications
10. Global Spatial OMICS Market, By Workflow (USD Million) 2021-2034
10.1. Sample preparation
10.2. Instrumental analysis
10.3. Data analysis
11. Global Spatial OMICS Market, By End-User (USD Million) 2021-2034
11.1. Academic & research institutes
11.2. Pharmaceutical and biotechnology companies
11.3. Contract research organizations
11.4. Other end-users
12. Global Spatial OMICS Market, (USD Million) 2021-2034
13.1. Global Spatial OMICS Market Size and Market Share
13. Global Spatial OMICS Market, By Region, (USD Million) 2021-2034
13.1. Asia-Pacific
13.1.1. Australia
13.1.2. China
13.1.3. India
13.1.4. Japan
13.1.5. South Korea
13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France
13.2.2. Germany
13.2.3. Italy
13.2.4. Spain
13.2.5. United Kingdom
13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia
13.3.2. United Arab Emirates
13.3.3. Qatar
13.3.4. South Africa
13.3.5. Egypt
13.3.6. Morocco
13.3.7. Nigeria
13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada
13.4.2. Mexico
13.4.3. United States
13.5. Latin America
13.5.1. Argentina
13.5.2. Brazil
13.5.3. Rest of Latin America
14. Company Profile
14.1. 10x Genomics
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. Akoya Biosciences, Inc
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Bio-Techne Corporation
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. BioSpyder, Inc
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. Bruker Corporation
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Danaher Corporation
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Diagenode Diagnostics (Hologic, Inc)
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Ionpath, Inc
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. Millennium Science Pty Ltd
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. NanoString Technologies, Inc
15.10.1. Company details
15.10.2. Financial outlook
15.10.3 Product summary
15.10.4. Recent developments
14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.